You have free access to this content

Epilepsia

Cover image for Vol. 54 Issue s4

Special Issue: Preclinical epilepsy therapy discovery

August 2013

Volume 54, Issue Supplement s4

Pages 1–74

  1. INTRODUCTION

    1. Top of page
    2. INTRODUCTION
    3. PRECLINICAL THERAPY DISCOVERY
    1. The ILAE and Wiley have published this supplement without financial support

      You have free access to this content
      Joint AES/ILAE translational workshop to optimize preclinical epilepsy research (pages 1–2)

      Aristea S. Galanopoulou, Michele Simonato, Jacqueline A. French and Terence J. O'Brien

      Version of Record online: 1 AUG 2013 | DOI: 10.1111/epi.12293

  2. PRECLINICAL THERAPY DISCOVERY

    1. Top of page
    2. INTRODUCTION
    3. PRECLINICAL THERAPY DISCOVERY
    1. You have free access to this content
      Development of new treatment approaches for epilepsy: Unmet needs and opportunities (pages 3–12)

      Jacqueline A. French, H. Steve White, Henrik Klitgaard, Gregory L. Holmes, Michael D. Privitera, Andrew J. Cole, Ellinor Quay, Samuel Wiebe, Dieter Schmidt, Roger J. Porter, Alexis Arzimanoglou, Eugen Trinka and Emilio Perucca

      Version of Record online: 1 AUG 2013 | DOI: 10.1111/epi.12294

    2. You have free access to this content
      Epilepsy therapy development: Technical and methodologic issues in studies with animal models (pages 13–23)

      Aristea S. Galanopoulou, Merab Kokaia, Jeffrey A. Loeb, Astrid Nehlig, Asla Pitkänen, Michael A. Rogawski, Kevin J. Staley, Vicky H. Whittemore and F. Edward Dudek

      Version of Record online: 1 AUG 2013 | DOI: 10.1111/epi.12295

    3. You have free access to this content
      Issues related to development of new antiseizure treatments (pages 24–34)

      Karen S. Wilcox, Tracy Dixon-Salazar, Graeme J. Sills, Elinor Ben-Menachem, H. Steve White, Roger J. Porter, Marc A. Dichter, Solomon L. Moshé, Jeffrey L. Noebels, Michael D. Privitera and Michael A. Rogawski

      Version of Record online: 1 AUG 2013 | DOI: 10.1111/epi.12296

    4. You have free access to this content
      Issues related to development of antiepileptogenic therapies (pages 35–43)

      Asla Pitkänen, Astrid Nehlig, Amy R. Brooks-Kayal, F. Edward Dudek, Daniel Friedman, Aristea S. Galanopoulou, Frances E. Jensen, Rafal M. Kaminski, Jaideep Kapur, Henrik Klitgaard, Wolfgang Löscher, Istvan Mody and Dieter Schmidt

      Version of Record online: 1 AUG 2013 | DOI: 10.1111/epi.12297

    5. You have free access to this content
      Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy (pages 44–60)

      Amy R. Brooks-Kayal, Kevin G. Bath, Anne T. Berg, Aristea S. Galanopoulou, Gregory L. Holmes, Frances E. Jensen, Andres M. Kanner, Terence J. O'Brien, Vicky H. Whittemore, Melodie R. Winawer, Manisha Patel and Helen E. Scharfman

      Version of Record online: 1 AUG 2013 | DOI: 10.1111/epi.12298

    6. You have free access to this content
      Epilepsy biomarkers (pages 61–69)

      Jerome Engel Jr., Asla Pitkänen, Jeffrey A. Loeb, F. Edward Dudek, Edward H. Bertram III, Andrew J. Cole, Solomon L. Moshé, Samuel Wiebe, Frances E. Jensen, Istvan Mody, Astrid Nehlig and Annamaria Vezzani

      Version of Record online: 1 AUG 2013 | DOI: 10.1111/epi.12299

    7. You have free access to this content
      Proposal for a “phase II” multicenter trial model for preclinical new antiepilepsy therapy development (pages 70–74)

      Terence J. O'Brien, Elinor Ben-Menachem, Edward H. Bertram III, Stephen D. Collins, Merab Kokaia, Holger Lerche, Henrik Klitgaard, Kevin J. Staley, Elisabetta Vaudano, Matthew C. Walker and Michele Simonato

      Version of Record online: 1 AUG 2013 | DOI: 10.1111/epi.12300

SEARCH

SEARCH BY CITATION